spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Nitric Oxide 

 HSMN NewsFeed - 3 Feb 2022
Third Pole Therapeutics Closes $25M Financing - eNOfit(TM) Wearable Device Now Ready for Clinical Trials
Devices Venture Capital
 HSMN NewsFeed - 20 Oct 2021
FDA Expands Approval of Dupixent(R) (dupilumab) to Include Children Aged 6 to 11 Years with Moderate-to-severe Asthma
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Jun 2021
vasopharm GmbH Announces Results of the NOSTRA III Traumatic Brain Injury Phase III Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Apr 2021
Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
Devices Venture Capital
 HSMN NewsFeed - 10 Nov 2020
Tezepelumab NAVIGATOR Phase 3 Trial Met Primary Endpoint Of A Statistically Significant And Clinically Meaningful Reduction In Exacerbations In A Broad Population Of Patients With Severe Asthma
Biopharmaceuticals
 HSMN NewsFeed - 8 Apr 2020
Third Pole Therapeutics Announces Global Commercialization Agreement with Chiesi Group for Its Tankless, Portable Inhaled Nitric Oxide (iNO) Delivery System
Biopharmaceuticals Licensing
 HSMN NewsFeed - 26 Mar 2020
FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL(R) DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 12 Mar 2020
Mallinckrodt Evaluates the Potential Role for Inhaled Nitric Oxide to Treat COVID-19 Associated Lung Complications, Engages with Scientific, Governmental and Regulatory Agencies
Biopharmaceuticals
 HSMN NewsFeed - 29 Jan 2020
vasopharm Completes Patient Enrollment for Phase III Traumatic Brain Injury Trial (NOSTRA)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Oct 2019
Third Pole Therapeutics Names Bill Athenson New CEO
Devices Drug Delivery Personnel
 HSMN NewsFeed - 6 Aug 2019
Dupixent(R) (dupilumab) Approved by European Commission for Adolescents with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 7 May 2019
Dupixent(R) (dupilumab) Approved for Severe Asthma by European Commission
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 May 2019
Mallinckrodt Announces Encouraging Interim Analysis Results in Phase 4 Registry of INOmax(R) (Nitric Oxide) Gas for Inhalation for Pulmonary Hypertension in Neonates
Biopharmaceuticals
 HSMN NewsFeed - 1 Mar 2019
CHMP Recommends Approval of Dupixent(R) (dupilumab) for Asthma Indication
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Dec 2018
Vast Therapeutics Announces Series A Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Oct 2018
FDA Approves Asthma Indication for Dupixent(R) (dupilumab)
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Aug 2018
AOBiome Therapeutics Announces the Expansion of its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2018
AOBiome Therapeutics Announces Election of Dr. Jun Wang as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2018
TrioxBio Announces Fast Track Designation Granted by U.S. FDA to Raviten(R) for the Treatment of Intradialytic Hypotension
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Jan 2018
Corsair Pharma and United Therapeutics Enter into Strategic Collaboration to Advance Novel Treprostinil Prodrugs
Biopharmaceuticals Licensing
 HSMN NewsFeed - 18 Dec 2017
Bausch & Lomb Begins Distribution Of VYZULTA(TM) (latanoprostene bunod ophthalmic solution), 0.024% To U.S. Wholesalers
Biopharmaceuticals Ophthalmology Product Launch
 HSMN NewsFeed - 24 Oct 2017
KNOW Bio Strengthens Leadership with the Addition of Four New Board Members
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2017
Novoteris, LLC Receives FDA and Health Canada Clearance to Start a Phase 2 Clinical Trial of Its Thiolanox(R) Nitric Oxide for the Treatment of Cystic Fibrosis
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 23 Sep 2016
Validity of Mallinckrodt's INOMAX(R) Patent Claims Upheld
Biopharmaceuticals Devices Litigation
 HSMN NewsFeed - 1 Feb 2016
Mallinckrodt Completes Acquisition Of Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company
Devices Surgery Acquisitions
 HSMN NewsFeed - 21 Jan 2016
vasopharm Announces EUR 20 Million Fundraising to Progress Treatment for Traumatic Brain Injury
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 30 Oct 2015
Mallinckrodt's INOmax(R) Approved In Australia And Japan For Pulmonary Hypertension In Conjunction With Heart Surgery
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Oct 2015
Novan Appoints Chief Financial Officer and Chief Commercial Officer to Leadership Team
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 15 Sep 2015
Bellerophon Therapeutics Announces Leadership Team Changes
Devices Drug Delivery Personnel
 HSMN NewsFeed - 1 May 2015
Advanced Inhalation Therapies Granted European Orphan Drug Designation for Nitric Oxide for the Treatment of Cystic Fibrosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Mar 2015
Novan Secures $50 Million Private Financing
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 7 Apr 2014
New Clinical Study Shows Masimo PVI(R) Helps Clinicians Optimize Fluid Administration in Patients Under Combined General and Epidural Anesthesia
Devices Monitoring
 HSMN NewsFeed - 10 Feb 2014
Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Jan 2014
Sequenom Laboratories grants Nicox exclusive promotion and marketing rights for its RetnaGene(TM) AMD test in North America
Diagnostics Ophthalmology Licensing
 HSMN NewsFeed - 6 Jan 2014
Soligenix Appoints Richard Straube, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2013
Aerocrine Signs Distribution Deal with Intramedic for Sweden
Devices Diagnostics Distribution
 HSMN NewsFeed - 23 Sep 2013
Bayer receives approval for Adempas(R) as first drug to treat rare heart and lung disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Sep 2013
Aerocrine Launches a New Fully Portable Hand-Held Device to Measure Airway Inflammation in Asthma
Devices Product Launch
 HSMN NewsFeed - 16 Apr 2013
Aerocrine’s NIOX MINO(R) device for measuring FeNO receives approval by Health Canada
Devices Regulatory
 HSMN NewsFeed - 4 Apr 2013
Aerocrine Passes Regulatory Milestone in Japan
Devices Regulatory
 HSMN NewsFeed - 2 Apr 2012
Aerocrine: The ACAAI & AAAAI issue a joint position statement in support of the American Thoracic Society (ATS) Guidelines on FeNO
Devices
 HSMN NewsFeed - 2 Apr 2012
NicOx appoints Philippe Masquida EVP, Managing Director of European Operations ; Next step in the Company's strategy to create an international ophthalmology company
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 21 Mar 2012
Jerry St. Peter appointed Executive Vice President and General Manager of NicOx Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2012
South Carolina Adopts Positive Coverage of Aerocrine’s FeNo Testing in Medicaid Program
Devices Reimbursement
 HSMN NewsFeed - 15 Aug 2011
Aerocrine Appoints Morten Gunvad as VP Commercial Operations Europe and Asia
Devices Personnel
 HSMN NewsFeed - 10 Jun 2011
MAQUET Cardiovascular Initiates Trial Comparing Use of MAQUET Pressure Controlling Syringe to Standard Syringe in Endoscopic Vessel Harvesting
Devices Cardiology
 HSMN NewsFeed - 29 Mar 2011
Aerocrine appoints Dr. Kathleen Rickard as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2011
FDA Extends Marketing Exclusivity for INOMAX(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Aug 2010
Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI(R) (epoprostenol for injection) for Pulmonary Arterial Hypertension
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jul 2010
FDA provides Complete Response Letter to NicOx's New Drug Application for naproxcinod
Biopharmaceuticals
 HSMN NewsFeed - 15 Jul 2010
Ikaria(R) Names Chief Science Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2010
Unigene Appoints New CEO, Ashleigh Palmer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2010
Ikaria(R) Names New Head of Research & Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2010
NicOx provides update on FDA Advisory Committee Meeting for naproxcinod
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Apr 2010
Actelion Pharmaceuticals Announces Commercial Availability of Epoprostenol for Injection for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 9 Mar 2010
FDA Clears GeNO LLC Investigational New Drug Application for Nitric Oxide Delivery System
Devices Drug Delivery
 HSMN NewsFeed - 3 Mar 2010
NicOx and Bausch & Lomb Announce Worldwide Licensing Agreement for NCX 116
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 2 Oct 2009
Arginetix Closes $10.75 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Sep 2009
Aerocrine: Canada Approves NIOX MINO for Asthma Monitoring
Devices Monitoring Regulatory
 HSMN NewsFeed - 13 May 2009
New Study Funded By the National Institutes of Health (NIH) Finds Masimo SpCO(R) May Provide a Noninvasive Measure of Acute Asthma Severity in Children
Devices Monitoring
 HSMN NewsFeed - 1 Apr 2009
NIMS Exer-Rest(R) Technology Linked to Reduced Brain Damage in Strokes
Devices Neurology
 HSMN NewsFeed - 24 Nov 2008
Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2008
NitroMed Announces Agreement to Sell BiDil(R) Drug Business to JHP Pharmaceuticals, LLC
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 8 Oct 2008
Apieron, Inc. Announces Appointment of Holly McGarraugh as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 15 Sep 2008
NicOx announces second naproxcinod pivotal phase 3 study (302) meets efficacy primary endpoints and supports non-detrimental blood pressure effect
Biopharmaceuticals
 HSMN NewsFeed - 2 Sep 2008
Ikaria(R) Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 25 Aug 2008
Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Aug 2008
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2008
Curacyte Sells Its Subsidiary Curacyte Discovery GmbH to The Medicines Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Aug 2008
The Medicines Company Acquires CU-2010 and Curacyte Discovery GmbH
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Aug 2008
TVM Capital Welcomes The Medicines Company in The European Market Through the Acquisition of Curacyte Discovery GmbH
Biopharmaceuticals Venture Capital Mergers & Acquisitions
 HSMN NewsFeed - 28 Jul 2008
Ikaria(R) Receives FDA Orphan Drug Designation for Inhaled Carbon Monoxide for Delayed Graft Function in Solid Organ Transplants
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Jul 2008
Ikaria(R) Strengthens Research & Development Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2008
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
Biopharmaceuticals
 HSMN NewsFeed - 2 Jun 2008
Rexahn Pharmaceuticals Initiates Phase II Trial for Zoraxel(TM) to Treat Erectile Dysfunction
Biopharmaceuticals
 HSMN NewsFeed - 29 May 2008
Gilead and Navitas Announce Agreement for Cicletanine for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 8 May 2008
Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2008
Atom Medical Adopts Masimo Rainbow SET Technology
Devices Monitoring
 HSMN NewsFeed - 8 Apr 2008
Aerocrine: Airway Inflammation Measurement Receives Reimbursement in Czech Republic
Diagnostics Reimbursement
 HSMN NewsFeed - 17 Mar 2008
Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
Devices FDA
 HSMN NewsFeed - 4 Mar 2008
FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma
Devices FDA
 HSMN NewsFeed - 1 Feb 2008
MediciNova's MN-166 Reduces Persistent Black Hole Formation in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Jan 2008
Nile Therapeutics Appoints Gregory W. Schafer to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2007
BioMarin Announces FDA Approval for Kuvan
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Dec 2007
New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2007
NIMS' Motion Platform Treatments Beneficial in Patients with Heart Failure and Peripheral Arterial Disease
Devices Cardiology
 HSMN NewsFeed - 12 Nov 2007
NicOx' naproxcinod phase 3 results presented at American College of Rheumatology
Biopharmaceuticals
 HSMN NewsFeed - 29 Oct 2007
N30 Pharma Announces License Agreement With NitroMed, Inc.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 23 Oct 2007
Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 18 Oct 2007
Nile Therapeutics Appoints Pedro Granadillo to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2007
NicOx opens US headquarters in New Jersey
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Oct 2007
Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting
Devices Monitoring
 HSMN NewsFeed - 2 Oct 2007
Aerocrine Submits 510(k) Filing for NIOX MINO(R) in the U.S.
Devices
 HSMN NewsFeed - 1 Oct 2007
Ikaria Names Executive Vice President of Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2007
Nile Therapeutics, Inc. Adds to Executive Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2007
Nile Therapeutics, Inc. Completes $20 Million Financing and Reverse Merger with SMI Products, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Aug 2007
Aerocrine Reinforces Management Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 20 Aug 2007
NeurAxon Announces $32 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Aug 2007
NeurAxon Appoints Robert Medve, M.D., as Chief Medical and Regulatory Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Aug 2007
Masimo Announces FDA Clearance for Additional Neonatal Parameters for Rainbow SET, Including Continuous and Noninvasive Measurement of Methemoglobin
Devices Monitoring FDA
 HSMN NewsFeed - 2 Jul 2007
NicOx appoints Pascal Pfister MD as Chief Scientific Officer and strengthens R&D organization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2007
NicOx Provides an Update on NCX 4016
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Apr 2007
NicOx recruits Sanjiv Sharma as Vice President Commercial Affairs in the United States
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Apr 2007
Power3 Medical Able to Offer Blood-Based Tests for Detection of Breast Cancer and Neurodegenerative Diseases after Receiving CLIA High-Complexity Certification
Diagnostics Personnel
 HSMN NewsFeed - 27 Mar 2007
MediciNova Announces Positive Clinical Results From MN-166 Phase II Multiple Sclerosis Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Mar 2007
Michael L. Sabolinski, M.D. Resigns from NitroMed
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2007
AGI Dermatics Data Shows Efficacy of Bicyclic Monoterpene Diols in Treatment of Molecular Markers of PhotoAged Skin
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 3 Jan 2007
Aerovance Announces Positive Top-Line Results from Phase 2a Trial of Inhaled AEROVANT(TM) in Asthma Patients
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2006
United Therapeutics Affiliate Initiates First-Ever Gene-Therapy Trial for Pulmonary Arterial Hypertension
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 12 Dec 2006
Northern Therapeutics and MaxCyte Initiate Landmark Engineered Cell Therapy Trial for Fatal Lung Disease
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 30 Nov 2006
Cardium Announces Formation of Scientific Advisory Board
Devices Personnel
 HSMN NewsFeed - 30 Nov 2006
Anesiva and Lumen Therapeutics Enter Agreement Granting Lumen Access to Data From Studies in Bypass Procedures
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 29 Nov 2006
Kalypsys Raises $100 Million in a Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Nov 2006
New CPT Code Awarded, for Asthma Tests Performed with NIOX(R) Nitric Oxide Monitoring System
Devices Monitoring Reimbursement
 HSMN NewsFeed - 10 Nov 2006
NicOx receives FDA feedback that no cardiovascular outcomes study required for naproxcinod NDA
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Oct 2006
NicOx Naproxcinod Phase 3 OA Trial Meets Primary Endpoints and Shows Encouraging Blood Pressure Profile
Biopharmaceuticals
 HSMN NewsFeed - 26 Oct 2006
Lipicard's Platrol(R) - First Safe, Sustained Release Antiplatelet Drug Developed Through a Novel Platform Technology
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 Oct 2006
Genaera Presents New EVIZON(TM) Safety Data at the Angiogenesis Foundation 4th Annual International Conference
Biopharmacetuicals Ophthalmology
 HSMN NewsFeed - 11 Oct 2006
NitroMed Revises Sales and Marketing Strategy - Accelerates Development of Extended Release BiDil(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Oct 2006
Thoratec's ITC Division Acquires A-VOX Systems
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 1 Jun 2006
Dr. Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 76

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 76 additional stories matching:
Nitric Oxide
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.